Search results
Results from the Tech24 Deals Content Network
Research in management of Ebola. Researcher working with the Ebola virus while wearing a BSL-4 positive pressure suit. There is a cure for the Ebola virus disease that is currently approved for market the US government has inventory in the Strategic National Stockpile. [ 1] For past and current Ebola epidemics, treatment has been primarily ...
Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a viral hemorrhagic fever in humans and other primates, caused by ebolaviruses. [1] Symptoms typically start anywhere between two days and three weeks after infection. [3] The first symptoms are usually fever, sore throat, muscle pain, and headaches. [1]
rVSV-ZEBOV. VSV-EBOV or rVSV-ZEBOV, sold under the brand name Ervebo, is a vaccine based on the vesicular stomatitis virus which was genetically modified to express a surface glycoprotein of Zaire Ebola virus. [ 16][ 17] In November 2019, the European Commission granted a conditional marketing authorization. [ 18]
Mali, which shares a border with Guinea, has implemented a contingency plan for prevention of Ebola Virus Disease. This involves a strong prevention system in several locations along the border, screening of incoming air passengers, a toll free phone number for notifying suspected cases, and stockpiles of drugs and equipment. [84]
The Centers for Disease Control and Prevention (CDC) is urging healthcare workers in the U.S. to consider Ebola when patients have symptoms, while airport officials are also screening passengers ...
The Kivu Ebola epidemic[ note 2] was an outbreak of Ebola virus disease (EVD) mainly in eastern Democratic Republic of the Congo (DRC), and in other parts of Central Africa, from 2018 to 2020. [ 10] Between 1 August 2018 and 25 June 2020 it resulted in 3,470 reported cases. [ 11]
Western African Ebola epidemic. Note: current estimates suggest that between 17 per cent and 70 per cent of Ebola cases were unreported, [ 11] suggesting a total number of cases between 34,513 and 94,486. The 2013–2016 epidemic of Ebola virus disease, centered in West Africa, was the most widespread outbreak of the disease in history.
Treatment using a transfusion of plasma from Ebola survivors, a form of "passive immunotherapy", [207] since it contains antibodies able to fight the virus, has been used with apparent success on a number of patients. [204] Survivor Kent Brantly donated his blood to Rick Sacra, Ashoka Mukpo and nurse Nina Pham.